Please login to the form below

Not currently logged in
Email:
Password:

Kate Paxton to lead Ketchum's UK healthcare practice

Agency also picks Neil McLelland for a leadership role at Inspired Science

Ketchum Kate Paxton

Ketchum has appointed Kate Paxton to lead its London healthcare offering, a move the agency said highlighted its commitment to its UK health business.

She takes over from Alison Doughty, who led Ketchum Health and was managing director of Ketchum’s med ed agency Inspired Science and will leave the agency next month.

Paxton was previously the director of the Washington, DC healthcare practice at Ketchum and has worked with the agency for the past 20 years.

She said: “I’m thrilled to join this well-established team. I look forward to using my experience leading a healthcare practice in the US to develop an even more collaborative, borderless approach to ensure we continue to deliver excellent results for our clients, while bringing exciting new opportunities to London.”

Ketchum Inspired Science Neil McLellandMeanwhile, Ketchum has also appointed as director of Inspired Science Neil McLelland, who arrives at the agency from a three-year spell as an executive director at Virgo Health Education.

“Kate and Neil bring a wealth of experience in healthcare communications, medical education and specialist team leadership, and I believe our clients will benefit greatly from their expertise,” said Denise Kaufmann, partner and CEO of Ketchum London. “Healthcare has always been a core driver for Ketchum London, and with this new influx of talent, we’re strengthening our existing business as well as accelerating our efforts in 2017.”

In their new roles at the Omnicom agency Paxton and McLelland will both report into Jo-Ann Robertson, partner and deputy CEO of Ketchum London.

Article by
Dominic Tyer

30th March 2017

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Page & Page

Page & Page is a new kind of marketing communications consultancy. We change beliefs and behaviours to improve health outcomes...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics